A team has identified cell type-specific gene expression signatures in blood samples from individuals with acute SARS-CoV-2 infections that appeared to predict the risk and types of long-term symptoms they may experience

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.

Roche announced on Monday that its Elecsys HCV Duo test for hepatitis C virus (HCV) received CE marking, and it is launching in countries accepting the regulatory approval.

On May 6, BGI Genomics Co.,Ltd. announced that it will rapidly provide a comprehensive detection and screening program for children with acute hepatitis of unknown cause.